# Study of Oral Palifosfamide Tris in Solid Tumors

> **NCT00607711** · PHASE1 · SUSPENDED · sponsor: **Alaunos Therapeutics** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** oral palifosfamide tris

## Key facts

- **NCT ID:** NCT00607711
- **Lead sponsor:** Alaunos Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2008-03
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** IND was withdrawn
- **Last updated:** 2008-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607711, "Study of Oral Palifosfamide Tris in Solid Tumors". Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/clinical/NCT00607711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*